Market revenue in 2022 | USD 13.0 million |
Market revenue in 2030 | USD 46.7 million |
Growth rate | 17.4% (CAGR from 2022 to 2030) |
Largest segment | Product |
Fastest growing segment | Service |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Product, Service |
Key market players worldwide | Azenta Inc, Tecan Group AG, Hamilton Lane Inc Class A, Evotec SE, LiCONiC, SPT Labtech, BioAscent, Beckman Coulter, Axxam |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to compound management market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 62.31% in 2022. Horizon Databook has segmented the Australia compound management market based on product, service covering the revenue growth of each sub-segment from 2018 to 2030.
Australia's compound management market is highly competitive, with both local and international players operating in the market. Some of the prominent players in the Australian compound management market include Evotec, Charles River Laboratories, Brooks Life Sciences, Hamilton Storage, and Labcyte.
These companies compete based on factors such as pricing, quality of service, range of services offered, and customer support. The increasing demand for drug discovery and development services in Australia is expected to drive the growth of the compound management market and further intensify competition among players in the market.
In Australia, the regulation of the compound management market is primarily overseen by the Therapeutic Goods Administration (TGA), which is a division of the Australian Government Department of Health. The TGA is responsible for regulating therapeutic goods, including drugs, medical devices, and biologicals, to ensure their safety, efficacy, and quality.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia compound management market , including forecasts for subscribers. This country databook contains high-level insights into Australia compound management market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account